Long-acting medicines for malaria, tuberculosis and hepatitis C
View More
Unitaid-funded projects develop innovative medicines, diagnostic tools and public health techniques and link them quickly, and at affordable prices, to those most in need.
Our grant projects apply the best that science has to offer to the fight against HIV and co-infections, tuberculosis and malaria in lower-resource countries.
Grant focus
To develop long-acting formulations of key medicines and create a market for them
Grantees
University of Liverpool
Status
Current
Amount
US$ 32,004,459
Disease
Hepatitis C, HIV and Co-Infection, Malaria, Tuberculosis
View More
Grant focus
Reducing transmission and improving access to hepatitis C treatment for key populations
Grantees
Frontline AIDS
Status
Current
Amount
US$ 9,218,918
Disease
Hepatitis C, HIV and Co-Infection
View More
Grantees
Médecins du Monde
Status
Current
Amount
US$ 9,363,092
Disease
Hepatitis C, HIV and Co-Infection
View More
Grantees
PATH
Status
Current
Amount
US$ 12,810,525
Disease
Hepatitis C, HIV and Co-Infection
View More
Grant focus
Improve screening and diagnostic tools for hepatitis C, particularly where patients have both HIV and hepatitis C
Grantees
FIND
Status
Complete
Amount
US$ 27,483,852
Disease
Hepatitis C, HIV and Co-Infection
View More
Grant focus
Partner with civil society to stimulate demand for hepatitis C treatment in target countries
Grantees
Coalition PLUS
Status
Complete
Amount
US$ 10,143,080
Disease
Hepatitis C, HIV and Co-Infection
View More
Grant focus
Develop simplified, adapted and affordable care models for hepatitis C for adoption in low- and middle-income countries
Grantees
Médecins Sans Frontières
Status
Complete
Amount
US$ 14,981,330
Disease
Hepatitis C, HIV and Co-Infection
View More